EIF2A and cancer: In conclusion, our study confirmed that pathways in cancer and gyroid hormone synthesis signaling pathway and two hub genes related to IS (CXCL12 and EIF2a) may be potential biomarker for accurate diagnosis and treatment of IS in future.